Investor Relations

Deep Sea Genomic opens financing opportunities exclusively to strategic Series (Venture Capital focused on DeepTech or Energy Transition) under a strict confidentiality framework.

Restricted Access

Due to the nature of our genetic patents and protocols in the Mexican biosphere, we do not provide public technical documentation beyond our market analysis.

Audit Process

If you represent a technology fund:

1. Contact us via our Investor channel.
2. You must sign an International NDA.
3. Detailed records of IRR, NPV, and in-situ demonstrations of accelerated COD (Chemical Oxygen Demand) degradation will be released.

For further inquiries, we kindly ask you to initiate the formal contact process.